Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald R Branch

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Transfusion|January 20, 2012
Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulinDanila Leontyev, Yulia Katsman, Xue-Zhong Ma, et al.
Transfusion|August 5, 2020
Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemiaEvgenia M Bloch, Haley A Branch, Darinka Sakac, et al.
European Journal of Haematology|February 18, 2018
Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposureSyed M Qadri, David A Donkor, Ishac Nazy, et al.
World Journal of Gastroenterology|September 2, 2024
Ferroptosis in liver diseases: Fundamental mechanism and clinical implicationsMing-Shuang Lai, Xi-Peng Yan, Donald R Branch, et al.
Transfusion|November 8, 2024
A novel small molecule phagocytosis inhibitor, KB-208, ameliorates ITP in mouse models with similar efficacy as IVIGMelika Loriamini, Melissa M Lewis-Bakker, Beth Binnington, et al.
Cancer Biology & Therapy|April 27, 2010
MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activityManujendra N Saha, Hua Jiang, Jennifer Jayakar, et al.
The Biochemical Journal|July 5, 2003
The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cellsPeixiang Wang, Donald R Branch, Meenakshi Bali, et al.
Medical Hypotheses|June 21, 2011
Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer?Milena Veljkovic, Donald R Branch, Violeta Dopsaj, et al.
Bioorganic & Medicinal Chemistry Letters|March 16, 2013
Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cellsMeena K Purohit, Iain Scovell, Anton Neschadim, et al.
Ejhaem|July 18, 2022
Mechanism of increased efficacy of recombinant Fc-μTP-L309C compared to IVIg to ameliorate mouse immune thrombocytopeniaBonnie J B Lewis, Beth Binnington, Megan Blacquiere, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Transfusion|January 20, 2012
Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulinDanila Leontyev, Yulia Katsman, Xue-Zhong Ma, et al.
Transfusion|August 5, 2020
Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemiaEvgenia M Bloch, Haley A Branch, Darinka Sakac, et al.
European Journal of Haematology|February 18, 2018
Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposureSyed M Qadri, David A Donkor, Ishac Nazy, et al.
World Journal of Gastroenterology|September 2, 2024
Ferroptosis in liver diseases: Fundamental mechanism and clinical implicationsMing-Shuang Lai, Xi-Peng Yan, Donald R Branch, et al.
Transfusion|November 8, 2024
A novel small molecule phagocytosis inhibitor, KB-208, ameliorates ITP in mouse models with similar efficacy as IVIGMelika Loriamini, Melissa M Lewis-Bakker, Beth Binnington, et al.
Cancer Biology & Therapy|April 27, 2010
MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activityManujendra N Saha, Hua Jiang, Jennifer Jayakar, et al.
The Biochemical Journal|July 5, 2003
The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cellsPeixiang Wang, Donald R Branch, Meenakshi Bali, et al.
Medical Hypotheses|June 21, 2011
Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer?Milena Veljkovic, Donald R Branch, Violeta Dopsaj, et al.
Bioorganic & Medicinal Chemistry Letters|March 16, 2013
Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cellsMeena K Purohit, Iain Scovell, Anton Neschadim, et al.
Ejhaem|July 18, 2022
Mechanism of increased efficacy of recombinant Fc-μTP-L309C compared to IVIg to ameliorate mouse immune thrombocytopeniaBonnie J B Lewis, Beth Binnington, Megan Blacquiere, et al.
Pageof 13